372 related articles for article (PubMed ID: 36043708)
21. Epidemiological and clinical aspects of nonsteroidal anti-inflammatory drugs and cancer risks.
Moran EM
J Environ Pathol Toxicol Oncol; 2002; 21(2):193-201. PubMed ID: 12086406
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandins and cancer.
Wang D; Dubois RN
Gut; 2006 Jan; 55(1):115-22. PubMed ID: 16118353
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms and applications of non-steroidal anti-inflammatory drugs in the chemoprevention of cancer.
Steele VE; Hawk ET; Viner JL; Lubet RA
Mutat Res; 2003; 523-524():137-44. PubMed ID: 12628511
[TBL] [Abstract][Full Text] [Related]
24. Phytochemical Targeting of Mitochondria for Breast Cancer Chemoprevention, Therapy, and Sensitization.
Zunica ERM; Axelrod CL; Kirwan JP
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430632
[TBL] [Abstract][Full Text] [Related]
25. Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment.
Krishnan AV; Feldman D
Endocr Relat Cancer; 2010 Mar; 17(1):R19-38. PubMed ID: 19926709
[TBL] [Abstract][Full Text] [Related]
26. Aspirin and NSAIDs for breast cancer chemoprevention.
Yiannakopoulou ECh
Eur J Cancer Prev; 2015 Sep; 24(5):416-21. PubMed ID: 25380191
[TBL] [Abstract][Full Text] [Related]
27. Nonsteroidal anti-inflammatory drugs and oxidative stress in cancer cells.
Adachi M; Sakamoto H; Kawamura R; Wang W; Imai K; Shinomura Y
Histol Histopathol; 2007 Apr; 22(4):437-42. PubMed ID: 17290354
[TBL] [Abstract][Full Text] [Related]
28. Chemoprevention of colorectal cancer: ready for routine use?
Arber N; Levin B
Recent Results Cancer Res; 2005; 166():213-30. PubMed ID: 15648192
[TBL] [Abstract][Full Text] [Related]
29. Chemoprevention of breast cancer.
Castrellon AB; Glück S
Expert Rev Anticancer Ther; 2008 Mar; 8(3):443-52. PubMed ID: 18366291
[TBL] [Abstract][Full Text] [Related]
30. Dietary cancer chemopreventive agents - targeting inflammation and Nrf2 signaling pathway.
Khor TO; Yu S; Kong AN
Planta Med; 2008 Oct; 74(13):1540-7. PubMed ID: 18937168
[TBL] [Abstract][Full Text] [Related]
31. Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer.
Schrör K
Best Pract Res Clin Gastroenterol; 2011 Aug; 25(4-5):473-84. PubMed ID: 22122764
[TBL] [Abstract][Full Text] [Related]
32. Aspirin as a chemopreventive agent for cutaneous melanoma: a literature review.
Pulumati A; Algarin YA; Jaalouk D; Kim S; Latta S; Nouri K
Arch Dermatol Res; 2024 Jun; 316(7):367. PubMed ID: 38850411
[TBL] [Abstract][Full Text] [Related]
33. NSAIDs inhibit tumorigenesis, but how?
Gurpinar E; Grizzle WE; Piazza GA
Clin Cancer Res; 2014 Mar; 20(5):1104-13. PubMed ID: 24311630
[TBL] [Abstract][Full Text] [Related]
34. Cyclooxygenase as a target for chemoprevention in colorectal cancer: lost cause or a concept coming of age?
Doherty GA; Murray FE
Expert Opin Ther Targets; 2009 Feb; 13(2):209-18. PubMed ID: 19236238
[TBL] [Abstract][Full Text] [Related]
35. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.
Thun MJ; Henley SJ; Patrono C
J Natl Cancer Inst; 2002 Feb; 94(4):252-66. PubMed ID: 11854387
[TBL] [Abstract][Full Text] [Related]
36. Effects of nonsteroidal anti-inflammatory agents (NSAIDs) on ovarian carcinoma cell lines: preclinical evaluation of NSAIDs as chemopreventive agents.
Rodríguez-Burford C; Barnes MN; Oelschlager DK; Myers RB; Talley LI; Partridge EE; Grizzle WE
Clin Cancer Res; 2002 Jan; 8(1):202-9. PubMed ID: 11801560
[TBL] [Abstract][Full Text] [Related]
37. The role of cyclooxygenase inhibitors in cancer prevention.
Anderson WF; Umar A; Viner JL; Hawk ET
Curr Pharm Des; 2002; 8(12):1035-62. PubMed ID: 11945150
[TBL] [Abstract][Full Text] [Related]
38. NSAIDs and chemoprevention.
Rao CV; Reddy BS
Curr Cancer Drug Targets; 2004 Feb; 4(1):29-42. PubMed ID: 14965265
[TBL] [Abstract][Full Text] [Related]
39. Cyclooxygenase-2 (COX-2), aromatase and breast cancer: a possible role for COX-2 inhibitors in breast cancer chemoprevention.
Davies G; Martin LA; Sacks N; Dowsett M
Ann Oncol; 2002 May; 13(5):669-78. PubMed ID: 12075734
[TBL] [Abstract][Full Text] [Related]
40. Cyclooxygenase-2: a novel target for cancer chemotherapy?
Dempke W; Rie C; Grothey A; Schmoll HJ
J Cancer Res Clin Oncol; 2001 Jul; 127(7):411-7. PubMed ID: 11469677
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]